We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · January 02, 2020

Phase II Report: Low-Concentration Atropine for Myopia Progression (LAMP) Study



Additional Info

Disclosure statements are available on the authors' profiles:

Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report
Ophthalmology 2019 Dec 20;[EPub Ahead of Print], JC Yam, FF Li, X Zhang, et al

Further Reading